药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603259 药明康德

已收盘 11-22 15:00:00

{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":49.63,"timestamp":1732258800000,"preClose":52.17,"halted":0,"volume":53904398,"delay":0,"floatShares":2501000000,"shares":2888000000,"eps":2.7921,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.54,"latestTime":"11-22 15:00:00","open":52.01,"high":52.01,"low":49.56,"amount":2733000000,"amplitude":0.047,"askPrice":49.63,"askSize":314,"bidPrice":49.62,"bidSize":521,"shortable":0,"etf":0,"ttmEps":2.7921,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":52.17,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":57.39,"lowLimit":46.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2887992582,"pbRate":2.6,"roa":"--","roe":"11.73%","epsLYR":3.27,"committee":-0.004683,"marketValue":143331000000,"floatMarketCap":124120000000,"peRate":17.775152,"changeRate":-0.0487,"turnoverRate":0.0216,"status":1},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2485743253","title":"药明康德：公司已在三季度报告中披露了截至报告期末的股东户数信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2485743253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485743253?lang=zh_cn&edition=full","pubTime":"2024-11-22 19:00","pubTimestamp":1732273235,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德11月22日在投资者关系平台上答复投资者关心的问题。若需进一步查询请将您的信息发送至公司投资者关系邮箱ir@wuxiapptec.com。公司已在三季度报告中披露了截至报告期末的股东户数信息。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200035544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","LU1997245177.USD","BK0216","BK1576","LU2125910500.SGD","LU0708995583.HKD","02359","BK1141","LU0052750758.USD","LU0456842615.SGD","LU0320764599.SGD","LU2242644610.SGD","LU2488822045.USD","BK1583","LU1997245094.SGD","LU1046422090.SGD","LU2045819591.USD"],"gpt_icon":0},{"id":"2485128228","title":"药明康德11月22日遭主力大幅抛售5.69亿元 环比增加320.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485128228","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485128228?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:19","pubTimestamp":1732259949,"startTime":"0","endTime":"0","summary":"11月22日, 药明康德股价跌4.87%，报收49.63元，成交金额27.33亿元，换手率2.16%，振幅4.70%，量比1.24。药明康德今日主力资金净流出5.69亿元，上一交易日主力净流出1.35亿元，今日环比增加320.21%。该股近5个交易日下跌6.13%，主力资金累计净流出8.79亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出23.40亿元，其中净流出天数为15日。净流出前三个股分别为药明康德、爱尔眼科、康龙化成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122152840abd6b728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122152840abd6b728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK0216","603259","LU1997245177.USD","LU0456842615.SGD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2485286328","title":"药明康德(02359)下跌5.01%，报46.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485286328","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485286328?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:24","pubTimestamp":1732256654,"startTime":"0","endTime":"0","summary":"11月22日，药明康德盘中下跌5.01%，截至14:24，报46.45元/股，成交3.34亿元。无锡药明康德新药开发股份有限公司是一家全球领先的一体化新药研发和生产服务提供商，主要通过其“CRDMO”和“CTDMO”业务模式，为全球生物医药行业提供包括化学药研发和生产、生物学研究、临床前测试和临床试验研究、细胞及基因疗法研发、测试和生产等在内的全方位服务。截至2024年三季报，药明康德营业总收入277.02亿元、净利润65.33亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/22142445568579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0216","BK1141","LU2045819591.USD","LU0456842615.SGD","LU0708995583.HKD","LU2125910500.SGD","BK1583","LU2488822045.USD","LU0052750758.USD","603259","02359","LU0320764599.SGD","BK1576","LU1046422090.SGD","LU1997245094.SGD","LU1997245177.USD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2485286985","title":"药明康德(02359)股价下跌5.01%，现价港币$46.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2485286985","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485286985?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:24","pubTimestamp":1732256640,"startTime":"0","endTime":"0","summary":"[下跌股]药明康德(02359) 股价在下午02:24比前收市价下跌5.01%，现股价为港币$46.45。至目前为止，今日最高价为$48.85，而最低价为$46.45。总成交量为703.612万股，总成交金额为港币$3.345亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411223681/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["603259","BK1141","BK0216","LU0052750758.USD","BK1576","LU2045819591.USD","LU2242644610.SGD","LU0708995583.HKD","LU1997245177.USD","BK1583","02359","LU0456842615.SGD","LU1997245094.SGD","LU2125910500.SGD","LU1046422090.SGD","LU2488822045.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2485453124","title":"药明康德(02359)出现大手买入10.77万股，成交价$48.7，涉资524.499万","url":"https://stock-news.laohu8.com/highlight/detail?id=2485453124","media":"阿斯达克财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485453124?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:40","pubTimestamp":1732174800,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在下午03:40出现大手买入，成交量为10.77万，成交价为港币$48.7，涉资524.499万。至目前为止，股价跌3.085%，今日最高价为$50.25，而最低价为$48.7，总成交量为381.347万股，总成交金额港币$1.878亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2411215825/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0320764599.SGD","LU2125910500.SGD","LU2045819591.USD","02359","LU2242644610.SGD","LU1046422090.SGD","603259","LU0456842615.SGD","LU0052750758.USD","LU2488822045.USD","LU1997245094.SGD","BK1583","LU0708995583.HKD","LU1997245177.USD","BK1141","BK1576","BK0216"],"gpt_icon":0},{"id":"2485822100","title":"药明康德11月20日遭南向资金减持61.76万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485822100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485822100?lang=zh_cn&edition=full","pubTime":"2024-11-21 09:30","pubTimestamp":1732152613,"startTime":"0","endTime":"0","summary":"11月20日，南向资金减持药明康德61.76万股。截止当日收盘，港股通共持有药明康德8903.47万股，占流通股22.99%。港股通减持金额前五个股分别为招商银行、中国财险、招商证券、中国铝业、中国海外发展。药明康德近5个交易日下跌8.55%，港股通累计减持143.91万股；近20个交易日下跌3.27%，港股通累计增持378.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121093206abd35ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121093206abd35ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","LU2045819591.USD","LU1046422090.SGD","LU2125910500.SGD","02359","BK1141","LU0320764599.SGD","603259","LU0052750758.USD","BK1583","LU0708995583.HKD","BK1576"],"gpt_icon":0},{"id":"2485362485","title":"药明康德获2024年EcoVadis企业社会责任评级\"金牌\"认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2485362485","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485362485?lang=zh_cn&edition=full","pubTime":"2024-11-21 08:00","pubTimestamp":1732147200,"startTime":"0","endTime":"0","summary":"上海2024年11月21日 /美通社/ -- 药明康德近日宣布，公司在2024年EcoVadis企业社会责任评级中获得金牌认证，位列所有参评公司前2%。这一评级不仅彰显了药明康德对可持续发展的坚定承诺，也体现了公司将环境及社会责任融入战略规划和业务运营的不懈努力。EcoVadis作为全球知名的企业社会责任和可持续发展评估平台，是全球企业衡量和提升业务和价值链可持续发展表现的重要参考指标。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4561900_ZH61900_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["WUXAY","603259","02359"],"gpt_icon":0},{"id":"2484715078","title":"药明康德11月20日主力净流入9973万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715078?lang=zh_cn&edition=full","pubTime":"2024-11-20 15:21","pubTimestamp":1732087274,"startTime":"0","endTime":"0","summary":"11月20日, 药明康德股价涨0.94%，报收52.57元，成交金额23.72亿元，换手率1.81%，振幅2.69%，量比0.82。药明康德今日主力资金净流入9973万元，上一交易日主力净流出7728万元。该行业中净流入前三个股分别为泰格医药、药明康德、康龙化成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120153820abd15185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120153820abd15185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456842615.SGD","LU1997245177.USD","LU1997245094.SGD","BK0216","LU2488822045.USD","603259"],"gpt_icon":0},{"id":"2484437139","title":"药明康德(02359)出现大手买入10.49万股，成交价$50.0，涉资524.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2484437139","media":"阿斯达克财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484437139?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:05","pubTimestamp":1732071900,"startTime":"0","endTime":"0","summary":"[大手成交]药明康德(02359)在上午11:05出现大手买入，成交量为10.49万，成交价为港币$50.0，涉资524.5万。至目前为止，股价跌0.498%，今日最高价为$51.1，而最低价为$49.5，总成交量为275.193万股，总成交金额港币$1.379亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2411204665/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["603259","LU2242644610.SGD","LU0456842615.SGD","LU0708995583.HKD","LU1997245094.SGD","02359","LU2125910500.SGD","LU1046422090.SGD","LU2045819591.USD","LU2488822045.USD","BK1141","LU0052750758.USD","LU1997245177.USD","LU0320764599.SGD","BK1576","BK0216","BK1583"],"gpt_icon":0},{"id":"2484095746","title":"中原证券：给予药明康德增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2484095746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484095746?lang=zh_cn&edition=full","pubTime":"2024-11-19 11:57","pubTimestamp":1731988644,"startTime":"0","endTime":"0","summary":"中原证券股份有限公司李琳琳近期对药明康德进行研究并发布了研究报告《季报点评：业绩改善，在手订单快速增长》，本报告对药明康德给出增持评级，当前股价为51.43元。　　预计公司2024年、2025年、2026年每股收益分别为3.16元，3.49元和3.83元，对应11月15日收盘价52.87元，动态市盈率分别为16.74倍，15.17倍和13.80倍，给予公司“增持”的投资评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900017095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603259","601375","02359"],"gpt_icon":0},{"id":"2484954785","title":"前海开源范洁旗下基金近3年来倒数第1，高位买入药明康德被深套","url":"https://stock-news.laohu8.com/highlight/detail?id=2484954785","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484954785?lang=zh_cn&edition=full","pubTime":"2024-11-19 11:27","pubTimestamp":1731986820,"startTime":"0","endTime":"0","summary":"不过，对于那些前期亏损过大的基金，近期的暴涨行情似乎影响不大。　　笔者发现，前海开源的医药女将范洁，即使近期医药板块强势反弹，但其旗下基金产品仍深陷亏损泥潭。范洁目前在管的基金产品有三只，分别是公共卫生股票、中药股票和医疗健康，但其中前海开源医疗健康A旗下有基金近3年亏62%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-19/doc-incwqkxu2970681.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-19/doc-incwqkxu2970681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","LU0708995583.HKD","LU1997245177.USD","LU0052750758.USD","LU2242644610.SGD","LU1997245094.SGD","LU0320764599.SGD","BK1583","02359","LU2045819591.USD","603259","LU2488822045.USD","BK1576","BK0216","LU2125910500.SGD","LU0456842615.SGD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2484971930","title":"药明康德11月18日遭南向资金减持59.60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484971930","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484971930?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:30","pubTimestamp":1731979814,"startTime":"0","endTime":"0","summary":"11月18日，南向资金减持药明康德59.60万股。截止当日收盘，港股通共持有药明康德8950.13万股，占流通股23.11%。港股通减持金额前五个股分别为协鑫科技、新秀丽、中兴通讯、中国财险、中国海外发展。药明康德近5个交易日下跌10.97%，港股通累计减持205.77万股；近20个交易日上涨0.10%，港股通累计增持430.26万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119093222a2444f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119093222a2444f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK0216","02359","LU1997245094.SGD","LU0456842615.SGD","603259","LU1997245177.USD"],"gpt_icon":0},{"id":"2484033614","title":"药明康德11月18日遭主力抛售1.97亿元 环比减少19.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484033614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484033614?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:20","pubTimestamp":1731914440,"startTime":"0","endTime":"0","summary":"11月18日, 药明康德股价跌2.36%，报收51.62元，成交金额25.14亿元，换手率1.93%，振幅3.29%，量比0.66。药明康德今日主力资金净流出1.97亿元，连续4日净流出，上一交易日主力净流出2.44亿元，今日环比减少19.36%。该股近5个交易日下跌10.12%，主力资金累计净流出10.73亿元；近20日主力资金累计净流出13.06亿元，其中净流出天数为13日。净流出前三个股分别为药明康德、爱尔眼科、康龙化成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154127a24230ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118154127a24230ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245177.USD","LU1997245094.SGD","LU2488822045.USD","BK0216","LU0456842615.SGD","603259"],"gpt_icon":0},{"id":"2483342132","title":"药明康德(02359)：WuXi Fund I拟认缴Sofinnova Capital XI SCSp SICAV-RAIF1000万欧元的投资基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2483342132","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483342132?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:41","pubTimestamp":1731663717,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德 发布公告，2024年11月15日，该公司全资子企业WuXi PharmaTech Healthcare Fund I L.P.与Sofinnova Capital XI GP S.à r.l.签署Subscription Agreement，约定由WuXi Fund I认缴Sofinnova Capital XI SCSp SICAV-RAIF1000万欧元的投资基金份额，约占已募集投资基金份额的4.40%。截至本公告日，WuXi Fund I尚未支付投资款，后续WuXi Fund I将以自有资金根据认购协议的要求履行投资款的支付义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1046422090.SGD","LU2045819591.USD","02359","LU0708995583.HKD","BK1141","LU1997245177.USD","BK1576","LU2125910500.SGD","LU2242644610.SGD","LU0052750758.USD","LU0456842615.SGD","LU2488822045.USD","LU0320764599.SGD","LU1997245094.SGD","603259","BK0216","BK1583"],"gpt_icon":0},{"id":"2483347939","title":"药明康德(02359.HK)认购1,000万欧元投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2483347939","media":"阿斯达克财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483347939?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:41","pubTimestamp":1731663660,"startTime":"0","endTime":"0","summary":"药明康德(02359.HK) 公布，以1,000万欧元认购投资基金Sofinnova Capital XI SCSp SICAV-RAIF，约占已募集投资基金份额的4.4%。该投资基金目标规模为5亿欧元，连同药明康德的1,000万欧元，已募集到2.283亿欧元。基金主要专注投资生命科技科学领域，特别是生物医药及医疗器械行业的初创企业。(vc/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-15 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220419153917927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220419153917927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397108/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1997245177.USD","LU1046422090.SGD","FXE","02359","LU2242644610.SGD","MEURmain","LU0708995583.HKD","LU2488822045.USD","LU1997245094.SGD","LU2045819591.USD","LU2125910500.SGD","BK0216","603259","BK1576","LU0456842615.SGD","LU0320764599.SGD","EUO","BK1141","EURmain","LU0052750758.USD","BK1583"],"gpt_icon":0},{"id":"2483341444","title":"药明康德：投资1000万欧元认购私募基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2483341444","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483341444?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:18","pubTimestamp":1731662311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2045819591.USD","LU1997245094.SGD","MEURmain","LU1046422090.SGD","LU1997245177.USD","LU2242644610.SGD","LU0052750758.USD","LU0456842615.SGD","603259","LU0708995583.HKD","BK1576","LU2488822045.USD","FXE","LU0320764599.SGD","EURmain","BK1583","BK0216","EUO","LU2125910500.SGD","BK1141","02359"],"gpt_icon":0},{"id":"2483334901","title":"药明康德(603259.SH)全资子企业拟认购1000万欧元投资基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334901","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334901?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:08","pubTimestamp":1731661716,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德 公告，2024年11月15日，公司全资子企业WuXi PharmaTech Healthcare Fund I L.P.与 Sofinnova Capital XI GP S.à r.l.签署 Subscription Agreement，约定由 WuXi Fund I 认缴 Sofinnova Capital XI SCSp SICAV-RAIF1000万欧元的投资基金份额，约占已募集投资基金份额的4.40% 。截至本公告日，WuXi Fund I尚未支付投资款，后续WuXi Fund I将以自有资金根据认购协议的要求履行投资款的支付义务。据悉，投资基金依据卢森堡大公国法律组建，专注于在世界范围内投资生命科学领域的初创企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","BK1141","BK0216","LU0052750758.USD","BK1576","LU2045819591.USD","LU2242644610.SGD","LU0708995583.HKD","LU1997245177.USD","BK1583","02359","LU0456842615.SGD","LU1997245094.SGD","LU2125910500.SGD","LU1046422090.SGD","LU2488822045.USD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2483310216","title":"药明康德11月15日遭主力抛售2.44亿元 环比减少47.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483310216","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483310216?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:22","pubTimestamp":1731655320,"startTime":"0","endTime":"0","summary":"11月15日, 药明康德股价跌2.81%，报收52.87元，成交金额28.59亿元，换手率2.13%，振幅2.90%，量比0.68。药明康德今日主力资金净流出2.44亿元，连续3日净流出，上一交易日主力净流出4.70亿元，今日环比减少47.97%。该股近5个交易日下跌5.79%，主力资金累计净流出7.84亿元；近20日主力资金累计净流出12.81亿元，其中净流出天数为13日。净流出前三个股分别为爱尔眼科、药明康德、康龙化成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154237a23a2fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154237a23a2fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245094.SGD","BK0216","LU2488822045.USD","603259","LU1997245177.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2483365009","title":"药明康德(02359.HK)常州研发中心正式启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2483365009","media":"阿斯达克财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483365009?lang=zh_cn&edition=full","pubTime":"2024-11-15 08:49","pubTimestamp":1731631740,"startTime":"0","endTime":"0","summary":"药明康德(02359.HK) (603259.SH) 宣布，其位于江苏常州的全新研发中心近日正式启用，进一步提升小分子、寡核苷酸、多肽及复杂化学偶联药物开发能力。该研发中心占地13.4万平方米。该中心进一步提升药明康德原料药工艺开发能力，更加高效地支持所有合成分子的生产需求的同时，能够更好地降本增效。(ta/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-14 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220419153918943_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220419153918943_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396862/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0052750758.USD","02359","BK1576","LU2125910500.SGD","LU2242644610.SGD","603259","LU0708995583.HKD","LU1046422090.SGD","LU1997245094.SGD","LU0456842615.SGD","LU1997245177.USD","BK1583","LU2488822045.USD","BK1141","LU2045819591.USD","BK0216","LU0320764599.SGD"],"gpt_icon":0},{"id":"2483584672","title":"药明康德(02359)股价下跌8.007%，现价港币$50.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584672","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584672?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:30","pubTimestamp":1731569400,"startTime":"0","endTime":"0","summary":"[下跌股]药明康德(02359) 股价在下午03:30比前收市价下跌8.007%，现股价为港币$50.55。至目前为止，今日最高价为$54.4，而最低价为$50.55。总成交量为962.61万股，总成交金额为港币$5.037亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411143372/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK0216","BK1576","LU2045819591.USD","LU1997245094.SGD","LU2488822045.USD","LU2125910500.SGD","LU0320764599.SGD","LU1997245177.USD","BK1141","LU1046422090.SGD","LU2242644610.SGD","LU0052750758.USD","02359","603259","LU0456842615.SGD","LU0708995583.HKD"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","stockEarnings":[{"period":"1week","weight":-0.041},{"period":"1month","weight":0.027},{"period":"3month","weight":0.3916},{"period":"6month","weight":0.251},{"period":"1year","weight":-0.3651},{"period":"ytd","weight":-0.265}],"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"288799万元","compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1808},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.1074},{"period":"ytd","weight":0.1329}],"survey":"　　无锡药明康德新药开发股份有限公司的主营业务是为全球生物医药行业提供一体化、端到端的新药研发和生产服务。公司主营业务可以分为化学业务、测试业务、生物学业务、细胞及基因疗法CTDMO业务、国内新药研发服务业务五大板块，服务范围覆盖从概念产生到商业化生产的整个流程，服务区域包括中国、美国、欧洲及其他区域。","serverTime":1732282403144,"listedPrice":21.6,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}